HU173920B - Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus - Google Patents

Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus

Info

Publication number
HU173920B
HU173920B HU75SA2736A HUSA002736A HU173920B HU 173920 B HU173920 B HU 173920B HU 75SA2736 A HU75SA2736 A HU 75SA2736A HU SA002736 A HUSA002736 A HU SA002736A HU 173920 B HU173920 B HU 173920B
Authority
HU
Hungary
Prior art keywords
neuraminidase
hemagglutinin
mixture
influenza virus
selective isolation
Prior art date
Application number
HU75SA2736A
Other languages
Hungarian (hu)
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU173920B publication Critical patent/HU173920B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HU75SA2736A 1974-01-14 1975-01-13 Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus HU173920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
HU173920B true HU173920B (en) 1979-09-28

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75SA2736A HU173920B (en) 1974-01-14 1975-01-13 Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
ES2359214T5 (en) * 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Viral vaccines derived from cells with reduced levels of residual cellular DNA by treatment with beta-propiolactone
SI2192917T1 (en) * 2007-08-28 2014-05-30 Baxter International Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
FR2257305B1 (en) 1982-03-19
DD116239A5 (en) 1975-11-12
ZA75259B (en) 1976-08-25
AU500250B2 (en) 1979-05-17
IE40794L (en) 1975-07-14
JPS50100224A (en) 1975-08-08
NO143128B (en) 1980-09-15
NL166622C (en) 1981-09-15
NL166622B (en) 1981-04-15
DK1475A (en) 1975-09-01
FI750014A (en) 1975-07-15
IE40794B1 (en) 1979-08-15
SU616997A3 (en) 1978-07-25
SE427238B (en) 1983-03-21
NO750031L (en) 1975-08-11
JPS58407B2 (en) 1983-01-06
ATA21475A (en) 1978-01-15
DE2500785A1 (en) 1975-07-31
DE2500785B2 (en) 1980-01-03
SE7500130L (en) 1975-07-15
ES433759A1 (en) 1977-02-16
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
YU5875A (en) 1984-04-30
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
DE2500785C3 (en) 1980-09-11
FR2257305A1 (en) 1975-08-08
IL46426A0 (en) 1975-04-25
FI54053B (en) 1978-06-30
GB1498261A (en) 1978-01-18
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
DK140003B (en) 1979-06-05
CH589453A5 (en) 1977-07-15
CA1049406A (en) 1979-02-27
MY8100204A (en) 1981-12-31
NO143128C (en) 1980-12-29
IL46426A (en) 1978-01-31
FI54053C (en) 1978-10-10
JPS6035326B2 (en) 1985-08-14
CS191254B2 (en) 1979-06-29
NL7500301A (en) 1975-07-16
YU41289B (en) 1987-02-28
PL93689B1 (en) 1977-06-30
AT345449B (en) 1978-09-11

Similar Documents

Publication Publication Date Title
YU37054B (en) Process for the preparation of structured soya
NL161462B (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION AND PROCEDURE FOR THE PREPARATION OF SUITABLE COMPOUNDS.
HU173920B (en) Process for the selective isolation of a mixture of hemagglutinin and neuraminidase from influenza virus
BE809668A (en) PROCESS FOR THE PREPARATION OF A REDUCING GAS
JPS51133414A (en) Production of vaccine against viral hepatisis
HU173548B (en) Process for preparing a recombinant strain of influenza virus and a vaccine containing this strain
BR7500319A (en) PROCESS FOR THE PREPARATION OF CLEANERS CONTAINING CYANOGRUPTS
IT1034411B (en) PROCESS FOR THE PREPARATION OF A MIXED CATALYST
IL48062A (en) Process for the preparation of meta-substituted halogenophenols
CH611518A5 (en) Process for the preparation of a virus subunit vaccine
HK70580A (en) New pharmaceutical compositions and a process for the preparation thereof
ZA753266B (en) New pharmaceutical compositions and a process for the preparation thereof
CH479700A (en) Process for obtaining a virus-containing allantoic fluid suitable for the production of influenza vaccines
PH13148A (en) A process for the preparation of triazapentadienes
PH12704A (en) Influenza vaccine containing a recombinant antigenically hybridized virus and method of using the same
PH13837A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
CH609031A5 (en) A process for the preparation of amines
ZA753988B (en) Process for the preparation of a methane-containing gas
IT1028106B (en) PROCEDURE FOR THE PREPARATION OF ALCYL SECONDARY PRIMARY AMINES FROM OXIME
CH613445A5 (en) Process for the preparation of novel N-(p-fluorobenzoylpropyl)-4-piperidylamides
JPS52156920A (en) Proauction of raw influenza virus vaccine
GB1485916A (en) Process for the preparation of propargyl amines and products obtained thereby
IL47771A (en) Process for the polymerization of isoprene
ZA723782B (en) A process for the preparation of steroids
AU492612B2 (en) Influenza vaccine containing a recombinant antigenically hybridized virus and method of using thesame

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee